BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1891443)

  • 1. Kinetics of lead in bone and blood after end of occupational exposure.
    Nilsson U; Attewell R; Christoffersson JO; Schütz A; Ahlgren L; Skerfving S; Mattsson S
    Pharmacol Toxicol; 1991 Jun; 68(6):477-84. PubMed ID: 1891443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo measurements of lead in fingerbone in active and retired lead smelters.
    Börjesson J; Gerhardsson L; Schütz A; Mattsson S; Skerfving S; Osterberg K
    Int Arch Occup Environ Health; 1997; 69(2):97-105. PubMed ID: 9001915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo measurements of lead in bone in long-term exposed lead smelter workers.
    Gerhardsson L; Attewell R; Chettle DR; Englyst V; Lundström NG; Nordberg GF; Nyhlin H; Scott MC; Todd AC
    Arch Environ Health; 1993; 48(3):147-56. PubMed ID: 8333784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead in finger bone, whole blood, plasma and urine in lead-smelter workers: extended exposure range.
    Schütz A; Olsson M; Jensen A; Gerhardsson L; Börjesson J; Mattsson S; Skerfving S
    Int Arch Occup Environ Health; 2005 Feb; 78(1):35-43. PubMed ID: 15750821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of lead in blood after the end of occupational exposure.
    Schütz A; Skerfving S; Ranstam J; Christoffersson JO
    Scand J Work Environ Health; 1987 Jun; 13(3):221-31. PubMed ID: 3616551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.
    Erkkilä J; Armstrong R; Riihimäki V; Chettle DR; Paakkari A; Scott M; Somervaille L; Starck J; Kock B; Aitio A
    Br J Ind Med; 1992 Sep; 49(9):631-44. PubMed ID: 1390269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead in vertebral bone biopsies from active and retired lead workers.
    Schütz A; Skerfving S; Christoffersson JO; Ahlgren L; Mattson S
    Arch Environ Health; 1987; 42(6):340-6. PubMed ID: 3439810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of skeletal lead levels in man after end of occupational exposure.
    Christoffersson JO; Ahlgren L; Schütz A; Skerfving S; Mattsson S
    Arch Environ Health; 1986; 41(5):312-8. PubMed ID: 3800436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead concentrations in tibial and calcaneal bone in relation to the history of occupational lead exposure.
    Bergdahl IA; Strömberg U; Gerhardsson L; Schütz A; Chettle DR; Skerfving S
    Scand J Work Environ Health; 1998 Feb; 24(1):38-45. PubMed ID: 9562399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism.
    Brito JA; McNeill FE; Stronach I; Webber CE; Wells S; Richard N; Chettle DR
    J Environ Monit; 2001 Aug; 3(4):343-51. PubMed ID: 11523432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead concentrations in cortical and trabecular bones in deceased smelter workers.
    Gerhardsson L; Akantis A; Lundström NG; Nordberg GF; Schütz A; Skerfving S
    J Trace Elem Med Biol; 2005; 19(2-3):209-15. PubMed ID: 16325538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead in finger-bone analysed in vivo in active and retired lead workers.
    Christoffersson JO; Schütz A; Ahlgren L; Haeger-Aronsen B; Mattsson S; Skerfving S
    Am J Ind Med; 1984; 6(6):447-57. PubMed ID: 6517074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead in fingerbone: a tool for retrospective exposure assessment.
    Börjesson J; Mattsson S; Strömberg U; Gerhardsson L; Schütz A; Skerfving S
    Arch Environ Health; 1997; 52(2):104-12. PubMed ID: 9124869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between bone lead and hemoglobin.
    Hu H; Watanabe H; Payton M; Korrick S; Rotnitzky A
    JAMA; 1994 Nov; 272(19):1512-7. PubMed ID: 7966843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study.
    Hu H; Wu MT; Cheng Y; Sparrow D; Weiss S; Kelsey K
    Environ Health Perspect; 2001 Aug; 109(8):827-32. PubMed ID: 11564619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence.
    Kosnett MJ; Becker CE; Osterloh JD; Kelly TJ; Pasta DJ
    JAMA; 1994 Jan; 271(3):197-203. PubMed ID: 8277545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Season modifies the relationship between bone and blood lead levels: the Normative Aging Study.
    Oliveira S; Aro A; Sparrow D; Hu H
    Arch Environ Health; 2002; 57(5):466-72. PubMed ID: 12641191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study.
    Hu H; Payton M; Korrick S; Aro A; Sparrow D; Weiss ST; Rotnitzky A
    Am J Epidemiol; 1996 Oct; 144(8):749-59. PubMed ID: 8857824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological monitoring of inorganic lead.
    Skerfving S; Nilsson U; Schütz A; Gerhardsson L
    Scand J Work Environ Health; 1993; 19 Suppl 1():59-64. PubMed ID: 8159975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.
    Hu H; Pepper L; Goldman R
    Am J Ind Med; 1991; 20(6):723-35. PubMed ID: 1805610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.